Board of Directors

Russell L. Carson

More →

Russell L. Carson

NYGC Board Co-Chair Chairman, The Carson Family Charitable Trust. Co-Founder and General Partner, Welsh, Carson, Anderson & Stowe
Ivan G. Seidenberg

More →

Ivan G. Seidenberg

NYGC Board Co-Chair Former Chair and Chief Executive Officer, Verizon Communications
Dafna Bar-Sagi, PhD

More →

Dafna Bar-Sagi, PhD

Professor of Biochemistry and Molecular Pharmacology and Medicine, Senior Vice President and Vice Dean for Science, Chief Scientific Officer, NYU Langone Health 
Dennis S. Charney, MD

More →

Dennis S. Charney, MD

Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai President for Academic Affairs, Mount Sinai Health System
Augustine M.K. Choi, MD

More →

Augustine M.K. Choi, MD

Stephen and Suzanne Weiss Dean, Weill Cornell Medicine, Provost for Medical Affairs, Cornell University
Nicholas Donofrio

More →

Nicholas Donofrio

Fellow Emeritus, Executive Vice President Innovation and Technology, IBM (retired)
John B. Ehrenkranz

More →

John B. Ehrenkranz

Chief Investment Officer, Ehrenkranz Partners
Anthony B. Evnin, PhD

More →

Anthony B. Evnin, PhD

Partner, Venrock
Lee Goldman, MD, MPH

More →

Lee Goldman, MD, MPH

Dean, Faculties of Health Sciences and Medicine and Chief Executive, Columbia University Irving Medical Center
Weslie R. Janeway

More →

Weslie R. Janeway

Director, Finistere Charitable Foundation
Richard P. Lifton, MD, PhD

More →

Richard P. Lifton, MD, PhD

President, The Rockefeller University
Edison T. Liu, MD

More →

Edison T. Liu, MD

President and Chief Executive Officer, The Jackson Laboratory
Tom Maniatis, PhD

More →

Tom Maniatis, PhD

NYGC Scientific Director and Chief Executive Officer, Founding Director, Columbia Precision Medicine Initiative, Isidore S. Edelman Professor and Chair, Department of Biochemistry and Molecular Biophysics, Columbia University
Cheryl A. Moore

More →

Cheryl A. Moore

NYGC President and Chief Operating Officer
Herbert Pardes, MD

More →

Herbert Pardes, MD

Executive Vice Chairman of the Board of Trustees, New York-Presbyterian Hospital
Frank E. Richardson, MA, JD

More →

Frank E. Richardson, MA, JD

Co-Founder & Senior Advisory Partner, Sentinel Capital Partners
Frank V. Sica

More →

Frank V. Sica

Partner, Tailwind Capital
Jim Simons, PhD

More →

Jim Simons, PhD

Chair, Simons Foundation Chair, Euclidean Capital, LLC Board Chair, Renaissance Technologies
Steven D. Singer

More →

Steven D. Singer

Partner, WilmerHale
Samuel L. Stanley Jr., MD

More →

Samuel L. Stanley Jr., MD

President, Stony Brook University
Bruce Stillman, PhD

More →

Bruce Stillman, PhD

President and Chief Executive Officer, Cold Spring Harbor Laboratory
Craig B. Thompson, MD

More →

Craig B. Thompson, MD

President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center
Gordon F. Tomaselli, MD, FAHA, FACC, FHRS

More →

Gordon F. Tomaselli, MD, FAHA, FACC, FHRS

The Marilyn and Stanley M. Katz Dean, Albert Einstein College of Medicine, Executive Vice President and Chief Academic Officer, Montefiore Medicine
Kevin J. Tracey, MD

More →

Kevin J. Tracey, MD

President and Chief Executive Officer, Feinein Institute for Medical Research, Professor of Neurosurgery and Molecular Medicine, Zucker school of Medicine at Hofstra/Northwel

Senior Management

Tom Maniatis, PhD

More →

Tom Maniatis, PhD

Scientific Director and Chief Executive Officer
  • Neurodegenerative diseases
Cheryl A. Moore

More →

Cheryl A. Moore

NYGC President and Chief Operating Officer
Carol Ashe

More →

Carol Ashe

Chief Business Officer
Ana Bastiani-Posner

More →

Ana Bastiani-Posner

Senior Vice President, Finance and Administration
Soren Germer, PhD

More →

Soren Germer, PhD

Senior Vice President, Genome Technologies
  • Computational biology
Kathleen Kearns

More →

Kathleen Kearns

Vice President, Development & Communications
Elizabeth O’Brien

More →

Elizabeth O’Brien

Vice President and General Counsel

Faculty and Senior Scientists

Scientific Director and Core Faculty

Tom Maniatis, PhD

More →

Tom Maniatis, PhD

Scientific Director
  • Neurodegenerative diseases
Marcin Imielinski, MD, PhD

More →

Marcin Imielinski, MD, PhD

Core Faculty Member
  • Cancer
Ivan Iossifov, PhD

More →

Ivan Iossifov, PhD

Core Faculty Member, Assistant Investigator
  • Neuropsychiatric Diseases
David A. Knowles, PhD

More →

David A. Knowles, PhD

Core Faculty Member
  • Functional genomics
Dan A. Landau, MD, PhD

More →

Dan A. Landau, MD, PhD

Core Faculty Member
  • Cancer
Tuuli Lappalainen, PhD

More →

Tuuli Lappalainen, PhD

Core Faculty Member
  • Functional genomics
Hemali Phatnani, PhD

More →

Hemali Phatnani, PhD

Director of the Center for Genomics of Neurodegenerative Disease
  • Neurodegenerative diseases
Neville Sanjana, PhD

More →

Neville Sanjana, PhD

Core Faculty Member
  • Cancer
  • Neuropsychiatric diseases
Rahul Satija, PhD

More →

Rahul Satija, PhD

Core Faculty Member
  • Functional Genomics

Senior Scientists

Toby Bloom, PhD

More →

Toby Bloom, PhD

Senior Director of Informatics, Strategic Genomic Analysis
  • Computational biology
Soren Germer, PhD

More →

Soren Germer, PhD

Senior Vice President, Genome Technologies
  • Computational biology
Nico Robine, PhD

More →

Nico Robine, PhD

Assistant Director, Computational Biology
  • Computational biology
Peter Smibert, PhD

More →

Peter Smibert, PhD

Manager, Technology Innovation
  • Technology Innovation
Michael Zody, PhD

More →

Michael Zody, PhD

Scientific Director of Computational Biology
  • Computational biology

Associate Members

Greg Hannon, PhD

More →

Greg Hannon, PhD

Senior Associate Core Member
  • Cancer
Simon Tavaré, PhD

More →

Simon Tavaré, PhD

Senior Associate Core Member
  • Cancer
Harold Varmus, MD

More →

Harold Varmus, MD

Senior Associate Core Member
  • Cancer
Mike Wigler, PhD

More →

Mike Wigler, PhD

Senior Associate Core Member
  • Neuropsychiatric diseases
Evan Eichler, PhD

More →

Evan Eichler, PhD

Associate Member
  • Neuropsychiatric diseases

Affiliate Members

The NYGC provides Affiliate Memberships to external academic researchers who have a significant interest in and commitment to the scientific life and work of the NYGC, and will contribute to and benefit from the NYGC’s mission.

Researchers who hold primary academic and/or clinical appointments at other institutions, including Institutional Founding Members and Institutional Associate Members, are eligible to be considered for an appointment as Affiliate Members.

The NYGC currently has 69 Affiliate Members, hailing from 14 academic institutions across the country. Please email Affiliate affiliate@nygenome.org if you are interested in applying to the program.

NYGC AFFILIATE MEMBERS

Cory Abate-Shen, PhD,
Columbia University
Michael Berger, PhD,
Memorial Sloan Kettering Cancer Center
Richard Bonneau, PhD,
New York University
Joseph Buxbaum, PhD,
Mount Sinai
Andrea Califano, PhD,
Columbia University
Lewis Cantley, PhD,
Weill Cornell Medicine
Aravinda Chakravarti, PhD,
New York University
Alexander Charney, MD, PhD,
Mount Sinai
Wendy Chung, MD, PhD,
Columbia University
Christopher Cunniff, MD,
Weill Cornell Medicine
Philip De Jager, MD, PhD,
Columbia University
Olivier Elemento, PhD,
Weill Cornell Medicine
Eleazar Eskin, PhD,
UCLA
Howard A. Fine, MD,
Weill Cornell Medicine
Fieke Froeling, MD, PhD,
Cold Spring Harbor Laboratory
Kevin Gardner, MD, PhD,
Columbia University
Jellert Gaublomme, PhD,
Columbia University
Thomas R. Gingeras, PhD,
Cold Spring Harbor Laboratory
Alison Goate, DPhil,
Mount Sinai
John Greally, MD, PhD,
Albert Einstein College of Medicine
Benjamin Greenbaum, PhD,
Mount Sinai
Cheryl Y. Hayashi, PhD,
American Museum of Natural History
George Hripcsak, MD,
Columbia University
Simon John, PhD,
The Jackson Laboratory
Marko Jovanovic, PhD,
Columbia University
Eimear Kenny, PhD,
Mount Sinai
Ekta Khurana, PhD,
Weill Cornell Medicine
Jennie Kline, PhD,
Columbia University
Andrew Kung, MD, PhD,
Memorial Sloan Kettering Cancer Center
Marc Ladanyi, MD,
Memorial Sloan Kettering Cancer Center
Ross Levine, MD,
Memorial Sloan Kettering Cancer Center
Steven Lipkin, MD, PhD,
Weill Cornell Medicine
David Lyden, MD, PhD,
Weill Cornell Medicine
Christopher Mason, PhD,
Weill Cornell Medicine
W. Richard McCombie, PhD,
Cold Spring Harbor Laboratory
Ari Melnick, MD,
Weill Cornell Medicine
Vilas Menon, PhD,
Columbia University
JJ Miranda, PhD,
Barnard College
Bud Mishra, PhD,
New York University
Parvathi A. Myer, MD,
Albert Einstein College of Medicine
Benjamin G. Neel, MD, PhD,
New York University
Kenneth Offit, MD
Memorial Sloan Ketting Cancer Center
William Oh, MD,
Mount Sinai
Ramon Parsons, MD, PhD,
Mount Sinai
Chiraag D. Patel, MD,
Stony Brook University
Scott Powers, PhD,
Stony Brook University
Molly Przeworski, PhD,
Columbia University
Raul Rabadan, PhD,
Columbia University
Ben Raphael, PhD,
Princeton University
M. Elizabeth Ross, MD, PhD,
Weill Cornell Medicine
Kevin A Roth, MD, PhD,
Columbia University
Panos Roussos, MD, PhD,
Mount Sinai
Anil Rustgi, MD,
Columbia University
Charles Sawyers, MD,
Memorial Sloan Kettering Cancer Center
Nikolaus Schultz, PhD,
Memorial Sloan Kettering Cancer Center
Sohrab P. Shah, PhD,
Memorial Sloan Kettering Cancer Center
Yufeng Shen, PhD,
Columbia University
Adam Siepel, PhD,
Cold Spring Harbor Laboratory
Jane Skok, PhD,
New York University
Barry Sleckman, MD, PhD,
Weill Cornell Medicine
Sohail Tavazoie, MD, PhD,
The Rockefeller University
Barry S. Taylor, PhD,
Memorial Sloan Kettering Cancer Center
David Tuveson, MD, PhD,
Cold Spring Harbor Laboratory
Krishna Veeramah, PhD,
Stony Brook University
Thomas Vierbuchen, PhD,
Memorial Sloan Kettering Cancer Center
Julia Wattacheril, MD,
Columbia University
George Weinstock, PhD,
The Jackson Laboratory
Itai Yanai, PhD,
New York University
Chaolin Zhang, PhD,
Columbia University

Scientific Working Groups

The NYGC has established scientific working groups with the objective of bringing together NYGC researchers and the scientific community to advance disease-based research in areas where our strengths and experience can make a significant difference.

  • Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center.
  • Neuropsychiatric Disease Working Group
  • Computational Cancer Genomics Working Group, led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center.
  • Enabling Innovation Working Group
  • Population Genomics Working Group, led by Adam Siepel, PhD, Cold Spring Harbor Laboratory, and Eimear Kenny, PhD, Icahn School of Medicine at Mount Sinai.
  • Genome Center Cancer Group, led by Harold Varmus, MD, NYGC and Weill Cornell, and Charles Sawyer, MD, Memorial Sloan Kettering Cancer Center.